| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY 40202
Choroidal neovascularization (CNV), or choroidal angiogenesis, is the hallmark of age-related macular degeneration and a leading cause of visual loss after age 55. The pathogenesis of new choroidal vessel formation is poorly understood. Although inflammation has been implicated in the development of CNV, the role of complement in CNV has not been explored experimentally. A reliable way to produce CNV in animals is to rupture Bruch’s membrane with laser photocoagulation. A murine model of laser-induced CNV in C57BL/6 mice revealed the deposition of C3 and membrane attack complex (MAC) in the neovascular complex. CNV was inhibited by complement depletion using cobra venom factor and did not develop in C3–/– mice. Anti-murine C6 Abs in C57BL/6 mice inhibited MAC formation and also resulted in the inhibition of CNV. Vascular endothelial growth factor, TGF-
2, and -fibroblast growth factor were elevated in C57BL/6 mice after laser-induced CNV; complement depletion resulted in a marked reduction in the level of these angiogenic factors. Thus, activation of complement, specifically the formation of MAC, is essential for the development of laser- induced choroidal angiogenesis in mice. It is possible that a similar mechanism may be involved in the pathophysiology of other angiogenesis essential diseases.
This article has been cited by other articles:
|
|
 |
|
  S. E. Yanni, J. M. Barnett, M. L. Clark, and J. S. Penn The Role of PGE2 Receptor EP4 in Pathologic Ocular Angiogenesis Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5479 - 5486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inomata, M. Fukushima, R. Hara, E. Takahashi, M. Honjo, T. Koga, T. Kawaji, H. Satoh, M. Takeya, T. Sawamura, et al. Suppression of Choroidal Neovascularization in Lectin-like Oxidized Low-Density Lipoprotein Receptor Type 1-Deficient Mice Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3970 - 3976. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Rohrer, Q. Long, B. Coughlin, R. B. Wilson, Y. Huang, F. Qiao, P. H. Tang, K. Kunchithapautham, G. S. Gilkeson, and S. Tomlinson A Targeted Inhibitor of the Alternative Complement Pathway Reduces Angiogenesis in a Mouse Model of Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3056 - 3064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Thurman, B. Renner, K. Kunchithapautham, V. P. Ferreira, M. K. Pangburn, Z. Ablonczy, S. Tomlinson, V. M. Holers, and B. Rohrer Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury J. Biol. Chem., June 19, 2009; 284(25): 16939 - 16947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Inomata, H. Tanihara, M. Tanito, H. Okuyama, Y. Hoshino, T. Kinumi, T. Kawaji, N. Kondo, J. Yodoi, and H. Nakamura Suppression of Choroidal Neovascularization by Thioredoxin-1 via Interaction with Complement Factor H Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5118 - 5125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Ferrara, J. E. Merriam, K. B. Freund, R. F. Spaide, B. S. Takahashi, I. Zhitomirsky, H. F. Fine, L. A. Yannuzzi, and R. Allikmets Analysis of Major Alleles Associated With Age-Related Macular Degeneration in Patients With Multifocal Choroiditis: Strong Association With Complement Factor H Arch Ophthalmol, November 1, 2008; 126(11): 1562 - 1566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Flierl, D. Rittirsch, B. A. Nadeau, D. E. Day, F. S. Zetoune, J. V. Sarma, M. S. Huber-Lang, and P. A. Ward Functions of the complement components C3 and C5 during sepsis FASEB J, October 1, 2008; 22(10): 3483 - 3490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Criswell, W.-Z. Hu, T. J. Steffens, R. Li, and P. Margaron Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model Arch Ophthalmol, July 1, 2008; 126(7): 946 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sivaprasad, T. Adewoyin, T. A. Bailey, S. S. Dandekar, S. Jenkins, A. R. Webster, and N. V. Chong Estimation of Systemic Complement C3 Activity in Age-Related Macular Degeneration Arch Ophthalmol, April 1, 2007; 125(4): 515 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Bora, S. Kaliappan, P. Jha, Q. Xu, B. Sivasankar, C. L. Harris, B. P. Morgan, and P. S. Bora CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration J. Immunol., February 1, 2007; 178(3): 1783 - 1790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ebrahem, K. Renganathan, J. Sears, A. Vasanji, X. Gu, L. Lu, R. G. Salomon, J. W. Crabb, and B. Anand-Apte Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration PNAS, September 5, 2006; 103(36): 13480 - 13484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Girardi, D. Yarilin, J. M. Thurman, V. M. Holers, and J. E. Salmon Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction J. Exp. Med., September 4, 2006; 203(9): 2165 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Bora, S. Kaliappan, P. Jha, Q. Xu, J.-H. Sohn, D. B. Dhaulakhandi, H. J. Kaplan, and P. S. Bora Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H J. Immunol., August 1, 2006; 177(3): 1872 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fosbrink, F. Niculescu, V. Rus, M. L. Shin, and H. Rus C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1 J. Biol. Chem., July 14, 2006; 281(28): 19009 - 19018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jha, J.-H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU). J. Immunol., June 15, 2006; 176(12): 7221 - 7231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jha, J.-H. Sohn, Q. Xu, H. Nishihori, Y. Wang, S. Nishihori, B. Manickam, H. J. Kaplan, P. S. Bora, and N. S. Bora The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1030 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nozaki, B. J. Raisler, E. Sakurai, J. V. Sarma, S. R. Barnum, J. D. Lambris, Y. Chen, K. Zhang, B. K. Ambati, J. Z. Baffi, et al. Drusen complement components C3a and C5a promote choroidal neovascularization PNAS, February 14, 2006; 103(7): 2328 - 2333. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
